Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 13 results for "hodgkin"

UK woman names her tumour after Trump
Rediff.com

UK woman names her tumour after Donald Trump

Elise Stapleton was left stunned when doctors told her she had Hodgkin lymphoma in Sept last year Business Standard, 1 month ago
Woman names her tumour after Trump Business Standard, 1 month ago
UK woman names her tumour after Trump Rediff.com, 1 month ago

192 images for hodgkin

Med India, 3 weeks ago
Cancer Therapy Advisor, 1 month ago
Peterborough Examiner, 1 month ago
The Press NZ, 1 month ago
LymphomaNewsToday.com, 2 months ago
AOL UK, 1 month ago
Peterborough Examiner, 2 months ago
VTDigger.org, 1 month ago
The Press NZ, 1 month ago
The Press NZ, 1 month ago
Med India

New Treatment Target for Aggressive Non-Hodgkin Lymphomas Identified

by Dr. Meenakshy Varier on March 1, 2017 at 11:54 AM Health Watch Highlights Aggressive forms of B cell lymphomas like Birkitt lymphoma and diffuse large cell lymphoma, often do not respond to chemotherapy and kill its victims. An alternative therapy using ...
 Med India3 weeks ago B-Cell Non-Hodgkin Lymphoma Risk in Middle Eastern Populations  Med India1 month ago

Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment

Norwegian biotech newcomer Nordic Nanovector ( NANOV.OL ), which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm. "We talk a lot with companies, and as the data improves and the company develops, the ...
 Reuters1 month ago

Prehistoric ancestor of leukaemia virus found in bats

Ancient DNA traces from the family of viruses that cause a rare type of leukaemia have been found in the genomes of bats, filling the "last major gap" in retrovirus fossil record, a new study has said. The research, which is published today in Proceedings of ...
 Business Standard3 weeks ago

Kite's shares fly high after cancer drug clears main study goal

Kite Pharma Inc said on Tuesday its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin's lymphoma, meeting the main goal of a key study. Kite's shares were up 15.85 percent at ...
 Reuters4 weeks ago

Dear men, work-related stress may cause cancer

Dear men, beware! Prolonged exposure to work-related stress may increase likelihood of cancer.The findings indicate that the link was observed in men, who had been exposed to 15 to 30 years of work-related stress and in some cases, more than 30 ...
 Business Standard2 months ago Work-related Stress in Men Can Cause Certain Cancers  Med India2 months ago Work-related stress may cause cancer in men: study  Business Standard2 months ago
Equitymaster.com

Sensex Opens Up 160 Points; Tata Steel Gains 0.8%

Posted by Equitymaster Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.03% while the Hang Seng is down 0.52%. The Shanghai Composite is trading down by 0.07%. Stock markets in the US ended their previous session on ...
 Equitymaster.com2 months ago

Natco Pharma gets USFDA approval for leukemia drug

Natco Pharma on Friday said it has received the USFDA approval to manufacture a drug for injections used in the treatement of chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma."We are pleased to announce the final approval of Abbreviated New Drug ...
 Prokerala2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less